1. Home
  2. ESGL vs TVGN Comparison

ESGL vs TVGN Comparison

Compare ESGL & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESGL
  • TVGN
  • Stock Information
  • Founded
  • ESGL 1999
  • TVGN 2020
  • Country
  • ESGL Singapore
  • TVGN United States
  • Employees
  • ESGL N/A
  • TVGN N/A
  • Industry
  • ESGL
  • TVGN Blank Checks
  • Sector
  • ESGL
  • TVGN Finance
  • Exchange
  • ESGL Nasdaq
  • TVGN Nasdaq
  • Market Cap
  • ESGL 165.3M
  • TVGN 179.0M
  • IPO Year
  • ESGL N/A
  • TVGN N/A
  • Fundamental
  • Price
  • ESGL $3.75
  • TVGN $0.42
  • Analyst Decision
  • ESGL
  • TVGN Strong Buy
  • Analyst Count
  • ESGL 0
  • TVGN 1
  • Target Price
  • ESGL N/A
  • TVGN $10.00
  • AVG Volume (30 Days)
  • ESGL 5.8K
  • TVGN 426.2K
  • Earning Date
  • ESGL 12-26-2025
  • TVGN 11-19-2025
  • Dividend Yield
  • ESGL N/A
  • TVGN N/A
  • EPS Growth
  • ESGL N/A
  • TVGN N/A
  • EPS
  • ESGL N/A
  • TVGN N/A
  • Revenue
  • ESGL $5,328,277.00
  • TVGN N/A
  • Revenue This Year
  • ESGL N/A
  • TVGN N/A
  • Revenue Next Year
  • ESGL N/A
  • TVGN N/A
  • P/E Ratio
  • ESGL N/A
  • TVGN N/A
  • Revenue Growth
  • ESGL N/A
  • TVGN N/A
  • 52 Week Low
  • ESGL $0.90
  • TVGN $0.42
  • 52 Week High
  • ESGL $4.32
  • TVGN $1.92
  • Technical
  • Relative Strength Index (RSI)
  • ESGL 44.10
  • TVGN 24.34
  • Support Level
  • ESGL $3.44
  • TVGN $0.46
  • Resistance Level
  • ESGL $3.95
  • TVGN $0.48
  • Average True Range (ATR)
  • ESGL 0.13
  • TVGN 0.05
  • MACD
  • ESGL -0.03
  • TVGN -0.01
  • Stochastic Oscillator
  • ESGL 57.41
  • TVGN 0.47

About ESGL ESGL Holdings Limited

ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.

About TVGN Tevogen Bio Holdings Inc. Common Stock

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Share on Social Networks: